TerminatedPhase 4

Random-start Ovarian Stimulation in Egg-donors (ROSE)

Stopped: Difficult recruitment

Spain15 participantsStarted 2017-01-10

Plain-language summary

The purpose of this prospective single-center study is to evaluate the laboratory outcome after random start ovarian stimulation in oocyte donors. The study will be performed in egg-donors but this type of treatment has the potential to be implemented in general infertility population.

Who can participate

Age range18 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Premenopausal women * 18-35 years old * FSH levels \< 10 IU/liter * Antral follicle count (AFC) \> 10 * Regular cycles * Body Mass Index (BMI) \< 28 * Signed informed consent Exclusion Criteria: * Polycystic ovary syndrome (PCOS) patients * Allergy to gonadotrophins * Concomitant participation in other trial

What they're measuring

Percentage of Mature Eggs

Timeframe: Up to 24 hours from the oocyte collection

Trial details

NCT IDNCT02821819

SponsorInstituto Bernabeu

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-01-12

Results submitted2018-09-16

View on ClinicalTrials.gov More Infertility trials